A Nomogram Model to Predict Post-Progression Survival in Esophageal Squamous Cell Carcinoma Patients With Recurrence After Radical Resection

被引:0
|
作者
Leng, Changsen [1 ,2 ,3 ]
Cui, Yingying [1 ,4 ]
Chen, Junying [1 ,2 ,3 ]
Wang, Kexi [5 ]
Yang, Hong [1 ,2 ,3 ]
Wen, Jing [1 ,3 ]
Fu, Jianhua [1 ,2 ,3 ]
Liu, Qianwen [1 ,2 ,3 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, Dept Thorac Surg, Guangzhou, Peoples R China
[3] Guangdong Esophageal Canc Inst, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Canc Ctr, Dept Hematol Oncol, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Thorac Surg, Guangzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
基金
中国博士后科学基金;
关键词
esophageal squamous cell carcinoma (ESCC); recurrence; post-progression survival; nomogram; prognostic model; CANCER; OUTCOMES;
D O I
10.3389/fonc.2022.925685
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Esophageal squamous cell carcinoma (ESCC) is characterized clinically by frequent recurrence, leading to a poor prognosis after radical surgery. The aim of this study was to identify a prognostic nomogram to predict the post-progression survival (PPS) of ESCC patients based on the features of primary tumor and recurrence. Methods: A total of 234 ESCC patients who underwent recurrence after radical surgery were enrolled in this study. The independent prognostic factors screened by the univariate and multivariate Cox regression analysis were subsequently used to construct a nomogram. The predictive performance of the nomogram was evaluated with the concordance index (C-index), decision curve, and the area under the receiver operating characteristic curve (AUC) and validated in two validation cohorts. The Kaplan-Meier curves of different recurrence patterns were analyzed. Results: The prognostic nomogram of PPS was established by integrating independent prognostic factors, including age, body mass index, number of lymph node dissection, recurrence pattern, and recurrence treatment. The nomogram demonstrated good performance, with C-index values of 0.756, 0.817, and 0.730 for the training and two validation cohorts. The 1-year AUC values were 0.773, 0.798, and 0.735 and 3-year AUC values were 0.832, 0.871, and 0.791, respectively. Furthermore, we found that patients with bone metastasis displayed the worst PPS compared to other isolated recurrence patterns. Conclusion: We constructed a nomogram to reliably predict PPS, which would be valuable to provide individual managements for ESCC patients after radical surgery.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy
    Wang, Peiliang
    Yang, Maoqi
    Wang, Xin
    Zhao, Zongxing
    Li, Minghuan
    Yu, Jinming
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (03)
  • [32] Nomogram based on immune scores for predicting the survival of patients with esophageal squamous cell carcinoma
    Wu, Wentao
    Ma, Wen
    Li, Daning
    Zheng, Shuai
    Zhao, Fanfan
    Feng, Xiaojie
    Lyu, Jun
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (04)
  • [33] Oligometastatic recurrence as a prognostic factor after curative resection of esophageal squamous cell carcinoma
    Takeshi Morinaga
    Masaaki Iwatsuki
    Kohei Yamashita
    Kazuto Harada
    Junji Kurashige
    Yohei Nagai
    Shiro Iwagami
    Yoshihumi Baba
    Naoya Yoshida
    Hideo Baba
    Surgery Today, 2021, 51 : 798 - 806
  • [34] Nomogram to predict prognosis in thoracic esophageal squamous cell carcinoma after neoadjuvant radiotherapy or chemoradiotherapy
    Deng, W.
    Wang, Q.
    Xiao, Z.
    Tan, L.
    Zhou, Z.
    Zhang, H.
    Chen, D.
    Feng, Q.
    Liang, J.
    He, J.
    Gao, S.
    Sun, K.
    Cheng, G.
    Liu, X.
    Fang, D.
    Xue, Q.
    Mao, Y.
    Wang, D.
    Li, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [35] Development and validation of nomogram to predict risk of survival in patients with laryngeal squamous cell carcinoma
    Cui, Jie
    Wang, Liping
    Zhong, Waisheng
    Chen, Zhen
    Tan, Xiaojun
    Yang, Hong
    Chen, Jie
    Liu, Genglong
    BIOSCIENCE REPORTS, 2020, 40
  • [36] Post-progression survival in patients with advanced hepatocellular carcinoma resistant to sorafenib
    Ogasawara, Sadahisa
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Suzuki, Eiichiro
    Kanogawa, Naoya
    Saito, Tomoko
    Motoyama, Tenyu
    Tawada, Akinobu
    Kanai, Fumihiko
    Yokosuka, Osamu
    INVESTIGATIONAL NEW DRUGS, 2016, 34 (02) : 255 - 260
  • [37] Nomogram predicting long-term survival probability of thoracic esophageal squamous cell carcinoma after radical esophagectomy.
    Mao, Weimin
    Zhou, Xinming
    Chen, Qixun
    Jiang, Youhua
    Yang, Xun
    Wu, Jie
    Tao, Kaiyi
    Zheng, Weihui
    Yan, Zhen
    Liu, Liang
    Wu, Shaoyuan
    Su, Dan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] Squamous cell carcinoma-antigen messenger RNA level in peripheral blood predicts recurrence after resection in patients with esophageal squamous cell carcinoma
    Honma, Hideyuki
    Kanda, Tatsuo
    Ito, Hiroaki
    Wakai, Toshifumi
    Nakagawa, Satoru
    Ohashi, Manabu
    Koyama, Yu
    Valera, Vladimir A.
    Akazawa, Kouhei
    Hatakeyama, Katsuyoshi
    SURGERY, 2006, 139 (05) : 678 - 685
  • [39] Post-progression survival in patients with advanced hepatocellular carcinoma resistant to sorafenib
    Sadahisa Ogasawara
    Tetsuhiro Chiba
    Yoshihiko Ooka
    Eiichiro Suzuki
    Naoya Kanogawa
    Tomoko Saito
    Tenyu Motoyama
    Akinobu Tawada
    Fumihiko Kanai
    Osamu Yokosuka
    Investigational New Drugs, 2016, 34 : 255 - 260
  • [40] A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma
    Liu, Jin-Shi
    Huang, Ying
    Yang, Xun
    Feng, Ji-Feng
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (07): : 2180 - 2189